Dr. Joseph G. Sokhn, MD

Dr. Sokhn practices at St. Luke's Hospital in Chesterfield, Missouri, part of St. Luke's Episcopal-Presbyterian Hospital.

Dr. Sokhn's NPI, 1912188426, was assigned on November 27, 2007. Dr. Sokhn graduated from Lebanese University School of Medicine in 2004. Dr. Sokhn holds Missouri license 2017015245.

Dr. Sokhn's primary practice is St. Luke's Hospital, at 232 S Woods Mill Rd, Chesterfield, MO 63017 in St. Louis County. The practice phone is (314) 434-1500.

Dr. Sokhn's primary practice is St. Luke's Hospital in Chesterfield, Missouri, part of St. Luke's Episcopal-Presbyterian Hospital. Dr. Sokhn is also affiliated with Missouri Baptist Medical Center. The medical group on file is Van Amburg & Busiek MDs. Dmand AI also links Dr. Sokhn to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sokhn practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sokhn's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sokhn is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sokhn's licenses on file in 4 states: Missouri, Illinois, Connecticut and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Sokhn treats.

CMS data shows 2,733 Medicare services from Dr. Sokhn across 9 procedure codes in 2024, for 450 Medicare patients. Medicare paid $205,826 for them.

CMS counts 450 Medicare patients who saw Dr. Sokhn in 2024. The largest group is 75 to 84, with 195 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sokhn's median patient age at 76, with 51% women.

In 2024, Dr. Sokhn wrote 1,377 Medicare Part D claims for 261 patients. 79% of them were for generic drugs. CMS names the drug for 1,189 of them, across 35 drugs with 11 or more claims each, at $2,878,488 in total drug cost. In 2023, CMS named 1,179 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Sokhn for performance year 2024, reported individually. Dr. Sokhn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sokhn as offering telehealth.

Dmand AI links 7 papers to Dr. Sokhn, published from 2013 to 2024. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Sokhn has published most often in Cureus. Dr. Sokhn's most frequent co-authors are Juliet F. Gibson, Edward Samuel James, MD and Maysa M. Abu-Khalaf, MD.

Dmand AI links Dr. Sokhn to 10 clinical trials, 7 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Anal Canal Carcinoma, Leukemia, Lymphocytic, Chronic, B-Cell and Lung Neoplasms. National Cancer Institute (NCI) sponsors the most, 10.

CMS Open Payments shows 154 general payments to Dr. Sokhn from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Seagen Inc. paid the most, $1,250.

Dr. Sokhn graduated from Lebanese University School of Medicine in 2004. Dr. Sokhn is a member of ACP, AMA, ASCO and ASH.

Dr. Sokhn is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.